Polar Asset Management Partners’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Polar Asset Management Partners’s Portfolio PEPL Stock Details PEPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100,000	Closed	-$1.09M	–	925
2023 Q4	$1.09M	Hold	100,000	–	–	0.02%	425
2023 Q3	$1.08M	Hold	100,000	–	–	0.02%	447
2023 Q2	$1.04M	Hold	100,000	–	–	0.02%	516
2023 Q1	$1.02M	Sell	100,000 -1,385,000	-93%	-$14.1M	0.02%	577
2022 Q4	$15.2M	Hold	1,485,000	–	–	0.19%	131
2022 Q3	$14.8M	Hold	1,485,000	–	–	0.18%	155
2022 Q2	$14.7M	Hold	1,485,000	–	–	0.17%	163
2022 Q1	$14.6M	Hold	1,485,000	–	–	0.16%	157
2021 Q4	$14.6M	Buy	+1,485,000	New	+$14.5M	0.15%	150

Polar Asset Management Partners's PEPL Position: Q1 2024 in Review

Polar Asset Management Partners sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2024, closing a stake of 100,000 shares — an estimated $1.09M sold.

Polar Asset Management Partners first reported a position in PEPL in Q4 2021 and held it in 9 quarters. The position peaked at $15.2M in Q4 2022. 0 funds tracked by Wall St. Rank hold PEPL as of Q1 2024.

Polar Asset Management Partners reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2024 after selling out during the quarter.
Polar Asset Management Partners sold 100,000 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2024, an estimated $1.09M.
Polar Asset Management Partners first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 9 quarters.
Polar Asset Management Partners's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $15.2M in Q4 2022.
0 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2024.

Based on Polar Asset Management Partners's 13F filing for Q1 2024, filed 15 May 2024.